Conceptus Inc: (NASD: CPTS)

$30.98

0.06 (0.19%)

Volume 387,138

May 21 04:00 PM ET

Zacks Rank: 1-Strong Buy

#1
 
 
 
 

Overview Quote

Get Overview Quote for:

Stock Activity

Day Low - High 30.93 - 30.98
52wk Low - High 15.81 - 31.10
Previous Close 30.92
Avg. Volume 1,902,887
Industry MED PRODUCTS
Market Cap 1.01 B
Div - Yield 0.00 - 0.00
Beta 0.75
PE (Forward) 118.35
Current Year Est. 0.26
Quarterly Earnings ESP -16.67%

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks #1 Rank Strong Buys

Rank Change Trend1

Zacks Recommendation Long-Term: 6+ Months

All Outperform Rated Stocks

Outperform

Zacks Industry Rank

179 out of 265

Equity Research Report

Updated as of 05/15/2013

PREMIUM

( = Change in last 30 days)

Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial

Key Earnings Data

PE (Forward) 118.35
PEG Ratio 5.92
Current Year Est. 0.26
Current Quarter Estimate 0.06
Most Accurate Estimate 0.05
Earnings ESP -16.67%
Next Earnings Report Date 08-06-2013
EPS Last Year 0.29
Expected Earnings Growth 20.00%

Company Description

Conceptus, Inc. designs and develops minimally invasive devices for reproductive medical applications. Conceptus' focus is to develop its STOP non-surgical permanent contraception device for women. STOP is designed to be a less-invasive, safer, and less costly alternative to surgical sterilization, more commonly known as tubal ligation. The STOP device is designed to achieve contraception by elliciting a tissue response which occludes the fallopian tubes.

NYSE data is at least 20 minutes delayed.

NASDAQ data is at least 15 minutes delayed.

Interactive Java Charting | Fundamental Charts

Introducing Zacks Whisper Trader

Turn Earnings Surprises into quick profits.

 

CPTS Chart by YCharts

Earnings Estimates

Current Qtr
(06/2013)
Next Qtr
(09/2013)
Current Year
(12/2013)
Next Year
(12/2014)
Average Estimate 0.06 0.07 0.26 0.41
Number of Estimates 7 7 8 6
Low Estimate 0.04 0.05 0.19 0.28
High Estimate 0.07 0.08 0.32 NA
Year Ago EPS 0.00 0.07 0.16 0.26
EPS Growth NA -4.08% 63.28% 55.02%

Average Earnings Estimates for CPTS

EPS Growth for CPTS

Industry Analysis

Name Symbol Previous Close Zacks Rank Zacks Recommendation
CONCEPTUS INC CPTS 30.92
ATRICURE INC ATRC 9.05
INVIVO THERAPT NVIV 2.89
TRANS1 INC TSON 1.69
ABAXIS INC ABAX 44.67
ADVAXIS INC ADXS 0.05
BAXTER INTL BAX 72.94
BIO-RAD LABS -A BIO 116.41
BIOLIFE SOL INC BLFS 0.41
BOSTON SCIENTIF BSX 9.25

Sector:Medical>> Industry:MED PRODUCTS

COMPARE TICKER vs. Its Peers

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.